CAFC-PTOOctober 8, 2026·26-1071·Dismissed.
Discussed on The Friday Patent Report, Episode 1 at 3:36
Sarepta Therapeutics, Inc. v. Trustees of the University of Pennsylvania
Patent Trial and Appeal Board
Holding
On the parties' agreement, the Federal Circuit dismissed Sarepta's appeal from the PTAB's IPR2024-00580 proceeding under Fed. R. App. P. 42(b), with each side bearing its own costs. The order decides no merits issue.
Why It Matters
The appeal ends by agreement with no ruling on the merits, so the order offers no guidance on any patent issue and the stated reasons for the dismissal are not disclosed.
Full Summary
Sarepta Therapeutics, Inc. v. Trustees of the University of Pennsylvania
On the parties' agreement, the Federal Circuit dismissed Sarepta's appeal from the PTAB's IPR2024-00580 proceeding under Fed. R. App. P. 42(b), with each side bearing its own costs. The order decides no merits issue.
The appeal ends by agreement with no ruling on the merits, so the order offers no guidance on any patent issue and the stated reasons for the dismissal are not disclosed.
Dismissed.
Sarepta Therapeutics, Inc. appealed from the PTAB in IPR2024-00580; the Trustees of the University of Pennsylvania and REGENXBIO Inc. are the appellees.
The court ordered the proceeding dismissed under Fed. R. App. P. 42(b) because the parties so agreed.
Each side bears its own costs.
The order issued as a mandate on October 8, 2026, and does not identify the patent, claims, or issues on appeal.
non-precedential
non-precedential
non-precedential
Key Points
- Sarepta Therapeutics, Inc. appealed from the PTAB in IPR2024-00580; the Trustees of the University of Pennsylvania and REGENXBIO Inc. are the appellees.
- The court ordered the proceeding dismissed under Fed. R. App. P. 42(b) because the parties so agreed.
- Each side bears its own costs.
- The order issued as a mandate on October 8, 2026, and does not identify the patent, claims, or issues on appeal.
How this summary was made: Drafted with AI from the court's opinion or order; before publishing, code checked that the quotation and the citations it gives appear in that document. Editorial policy
New to Federal Circuit? See our Federal Circuit page